{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:31:00Z","timestamp":1790375460818,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERES"],"award-info":[{"award-number":["CIBERES"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["Observationship Programme"],"award-info":[{"award-number":["Observationship Programme"]}],"id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10096-018-3428-y","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:57:21Z","timestamp":1542113841000},"page":"319-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0676-6210","authenticated-orcid":false,"given":"Jordi","family":"Rello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Kalwaje Eshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Lagunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Wunderink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Conway-Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Nicolas","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"3428_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00134-017-5036-1","volume":"44","author":"J Waale De","year":"2018","unstructured":"De Waale J, Akova M, Antonelli M et al (2018) Antimicrobial resistance and antibiotic stewardship programs in the ICU: a position statement from ESICM\/ESCMID\/WAAAR round table on multidrug resistance. Intensive Care Med 44:189\u2013196","journal-title":"Intensive Care Med"},{"key":"3428_CR2","unstructured":"National efforts to combat antibiotic-resistant bacteria through science | NIH: National Institute of Allergy and Infectious Diseases n.d. \n                    https:\/\/www.niaid.nih.gov\/news-events\/national-efforts-combat-antibiotic-resistant-bacteria-through-science\n                    \n                   (Accessed Aug 2, 2018)"},{"key":"3428_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A et al (2018) Discovery, research and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318\u2013327","journal-title":"Lancet Infect Dis"},{"key":"3428_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00134-014-3258-z","volume":"40","author":"JC Lucet","year":"2014","unstructured":"Lucet JC, Koulenti D, Zahar JR (2014) Persistence of colonization with MDRO following discharge from the ICU. Intensive Care Med 40:603\u2013605","journal-title":"Intensive Care Med"},{"key":"3428_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"D Sievert","year":"2013","unstructured":"Sievert D, Ricks P, Edwards J, Schneider A, Patel J, Srinivasan A et al (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34:1\u201314","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3428_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281","journal-title":"Clin Microbiol Infect"},{"key":"3428_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.cmi.2015.09.021","volume":"21","author":"JA Otter","year":"2015","unstructured":"Otter JA, Mutters NT, Tacconelli E, Gikas A, Holmes AH (2015) Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect 21:1057\u20131066","journal-title":"Clin Microbiol Infect"},{"key":"3428_CR8","unstructured":"WHO. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. Essent Med Heal Prod 2017:88. doi:WHO reference number: WHO\/EMP\/IAU\/2017.12"},{"key":"3428_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00134-017-4796-y","volume":"43","author":"G Poulakou","year":"2017","unstructured":"Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ et al (2017) \u201cSalvage treatment\u201d for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal. Intensive Care Med 43:1164\u20131166","journal-title":"Intensive Care Med"},{"key":"3428_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.eimc.2014.02.006","volume":"32","author":"R Zaragoza","year":"2014","unstructured":"Zaragoza R, Ramirez P, Lopez-Pueyo MJ (2014) Nosocomial infections in intensive care units. Enferm Infecc Mircobiol Clin 32:320\u2013327","journal-title":"Enferm Infecc Mircobiol Clin"},{"key":"3428_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s10096-017-3039-z","volume":"36","author":"B Borgatta","year":"2017","unstructured":"Borgatta B, Gattarello S, Mazo CA, Imbiscuso AT, Larrosa MN, Lujan M et al (2017) The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs. Eur J Clin Microbiol Infect Dis 36:2155\u20132163","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3428_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","volume":"17","author":"H Grundmann","year":"2017","unstructured":"Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevi\u0107 AT et al (2017) Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 17:153\u2013163","journal-title":"Lancet Infect Dis"},{"key":"3428_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1055\/s-0043-119958","volume":"143","author":"WV Kern","year":"2018","unstructured":"Kern WV (2018) Multidrug resistant bacteria: antibiotic prescription and antibiotics of last resort. DDtsch Med Wochenschr 143:643\u2013650","journal-title":"DDtsch Med Wochenschr"},{"key":"3428_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-015-0926-5","volume":"19","author":"ST Micek","year":"2015","unstructured":"Micek ST, Wunderinck RG, Kollef MH et al (2015) An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care 19:219","journal-title":"Crit Care"},{"key":"3428_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH (2014) Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 18:596","journal-title":"Crit Care"},{"key":"3428_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/civ227","volume":"61","author":"DL Paterson","year":"2015","unstructured":"Paterson DL, Harris PNA (2015) Editorial Commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble. Clin Infect Dis 61:155\u2013156","journal-title":"Clin Infect Dis"},{"key":"3428_CR17","unstructured":"Health care-associated infections FACT SHEET. \n                    http:\/\/www.who.int\/gpsc\/country_work\/gpsc_ccisc_fact_sheet_en.pdf\n                    \n                  . Accessed Nov 5th, 2018"},{"key":"3428_CR18","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ajic.2016.04.212","volume":"44","author":"M Talaat","year":"2016","unstructured":"Talaat M, El-Shokry M, El-Kholy J, Ismail G, Kotb S, Hafez S et al (2016) National surveillance of health care\u2013associated infections in Egypt: developing a sustainable program in a resource-limited country. Am J Infect Control 44:1296\u20131301","journal-title":"Am J Infect Control"},{"key":"3428_CR19","doi-asserted-by":"publisher","unstructured":"Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S et al (2016) Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. Elife 5. \n                    https:\/\/doi.org\/10.7554\/eLife.18082","DOI":"10.7554\/eLife.18082"},{"key":"3428_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00134-017-4795-z","volume":"44","author":"AM Dondorp","year":"2018","unstructured":"Dondorp AM, Limmathurotsakul D, Ashley EA (2018) What\u2019s wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries? Intensive Care Med 44:79\u201382","journal-title":"Intensive Care Med"},{"key":"3428_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3855\/jidc.6832","volume":"9","author":"E Alp","year":"2015","unstructured":"Alp E, Damani N (2015) Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. J Infect Dev Ctries 9:1040\u20131045","journal-title":"J Infect Dev Ctries"},{"key":"3428_CR22","doi-asserted-by":"publisher","first-page":"e0165242","DOI":"10.1371\/journal.pone.0165242","volume":"11","author":"AA Iwuafor","year":"2016","unstructured":"Iwuafor AA, Ogunsola FT, Oladele RO, Oduyebo OO, Desalu I, Egwuatu CC et al (2016) Incidence, clinical outcome and risk factors of intensive care unit infections in the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. PLoS ONE\u00a011:e0165242. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0165242","journal-title":"PLoS ONE"},{"key":"3428_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","volume":"274","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al (1998) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC international advisory committee. JAMA 274:639\u2013644","journal-title":"JAMA"},{"key":"3428_CR24","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323\u20132329. \n                    https:\/\/doi.org\/10.1001\/jama.2009.1754","journal-title":"JAMA"},{"key":"3428_CR25","doi-asserted-by":"crossref","unstructured":"Belton V, Stewart TJ (2002) Multiple criteria decision analysis: an integrated approach. Springer US","DOI":"10.1007\/978-1-4615-1495-4"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3428-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3428-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3428-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T19:25:14Z","timestamp":1573586714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3428-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3428"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3428-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Rello served in the speaker\u2019s bureau or consultant for Pfizer, Anchoagen, ROCHE. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}